Physician profile
Wei Fan
NPI 1053499863
$2,963.81
in general payments reported to CMS, 2019-2025
19 companies · $332 in 2025
The $332 reported for 2025 was more than what 85% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $24.11 · 2021: $589 · 2022: $35.29 · 2023: $783 · 2024: $583 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,698.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $494.58 | 2019-2024 | Andexxa, Breztri |
| Lilly USA, LLC | $464.83 | 2019-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $395.26 | 2020-2023 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $308.34 | 2023-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $190.31 | 2019 | |
| Glaxosmithkline, LLC. | $161.79 | 2021-2023 | Arexvy |
| Teva Pharmaceuticals USA, INC. | $127.44 | 2023 | Austedo |
| Abbvie INC. | $116.29 | 2021-2024 | |
| Gilead Sciences, INC. | $88.56 | 2024 | Livdelzi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $86.11 | 2023 | |
| Amgen INC. | $85.17 | 2019 | |
| Amarin Pharma, INC. | $83.97 | 2019 | |
| Ani Pharmaceuticals, INC. | $82.75 | 2025 | Purified Cortrophin Gel |
| Alkermes, INC. | $78.46 | 2023 | Lybalvi |
| Bayer Healthcare Pharmaceuticals INC. | $67.11 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $59.24 | 2019 | |
| Novo Nordisk INC | $34.44 | 2022-2023 | Ozempic, Rybelsus |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.02 | 2025 | Lifevest |
| Pfizer INC. | $19.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wei Fan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.